News

See the latest in our fight to end neurodegenerative disease.

  • Libra Therapeutics Appoints Dr. Shawn A. Scranton as President and Chief Executive Officer

    READ MORE
  • Libra Therapeutics Appoints Gene Kinney, Ph.D., Chairperson of the Company’s Board of Directors

    READ MORE
  • John Renger, Ph.D., Appointed to Libra’s Scientific Advisory Board

    READ MORE
  • Libra Therapeutics Appoints Gene Kinney, Ph.D., to Its Board of Directors

    READ MORE
  • Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

    READ MORE

Your privacy is important to us. By using this site, you agree to our Terms of Use and use of cookies.

I AGREE